Conditions: Epilepsy
Keywords: Levetiracetam Epilepsy Children Adults
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 25
Healthy volunteers: no

Brief summary:
To study how the body absorbs, distributes, metabolises and eliminates Keppra XR in both children (12 to 16 years old) and adults (18 to 55 years old) with epilepsy.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Keppra XR
Intervention descriptions: intervention 1: Keppra XR 500 mg tablets and Keppra XR 750 mg tablets

Dosage: Keppra XR 1000-3000 mg/day taken once daily. Duration: 4-7 days

Protocol document: